1 - 25 of 2
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (video)Heather E. Moss, MD, PhDThe landscape of therapies for multiple sclerosis (MS) is constantly shifting. Currently, there are 11 FDA approved agents for chronic disease treatment, multiple drugs in clinical trials for acute and chronic disease management and numerous compounds used for symptom control. Beyond treating patien...20170406_nanos_nosideeffects1_04-video
2 Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (abstract)Heather E. Moss, MD, PhDThe landscape of therapies for multiple sclerosis (MS) is constantly shifting. Currently, there are 11 FDA approved agents for chronic disease treatment, multiple drugs in clinical trials for acute and chronic disease management and numerous compounds used for symptom control. Beyond treating patien...20170406_nanos_nosideeffects1_04-abstract
1 - 25 of 2